Filing Flows › Xenetic Biosciences (XBIO) › How it makes money
How Xenetic Biosciences (XBIO) makes money
Xenetic Biosciences (XBIO) made $661K of revenue in the second quarter 2026 (Q2 2026), +12% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $661K | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $661K | +12% |
| Q1 2026 | $807K | +36% |
| Q4 2025 | $766K | +18% |
| Q3 2025 | $1.0M | +67% |
| Q2 2025 | $590K | -19% |
| Q1 2025 | $593K | +16% |
| Q4 2024 | $649K | -3% |
From Xenetic Biosciences' 10-Q filed Aug 6, 2026 (on EDGAR).
Questions
How does Xenetic Biosciences make money?
Xenetic Biosciences (XBIO) made $661K of revenue in the second quarter 2026 (Q2 2026), +12% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.